Abstract
Polycystic ovary syndrome (PCOS) is a prevalent condition in women of reproductive age. It is characterized by androgen excess and chronic anovulation. Some trace elements, macroelements, and heavy metals have been linked to pathophysiological mechanisms of PCOS .
 To study the alterations in the serum levels of the trace element manganese (Mn), some macroelements, magnesium(Mg) and calcium (Ca), and the heavy metals cadmium (Cd) and lead (Pb), in obese and non-obese PCOS patients; and the association of these alterations with some of the hormonal changes occurring in PCOS.
 The study was carried out at Kamal Al-Samarrai Hospital (Center for Infertility treatment and in vitro Fertilization "IVF") Baghdad- Iraq. Eighty-two women were enrolled in the study. Fifty-four of them were diagnosed by a specialist gynecologist as PCOS patients; they were subdivided into two subgroups according to their body mass index (BMI); twenty-seven obese PCOS patients with BMI > 30 kg/m2, and another twenty seven non obese patients PCOS with BMI <30 kg/m2. Whereas, twenty-eight apparently healthy women with regular menstruation and of comparable age, were selected to serve as control groups; they were subdivided into, fourteen obese women with BMI > 30kg/m2, and fourteen non obese women with BMI <30 kg/m2.
 Blood lead and cadmium levels were significantly higher in both of the obese and the non-obese PCOS groups, than in their corresponding control groups. While, serum magnesium, calcium and manganese levels were significantly lower in both of the obese and the non-obese PCOS groups, as compared to their corresponding control groups. The results revealed no significant difference in the levels of the measured elements, between the obese PCOS group and the non-obese PCOS group. The serum FSH levels was significantly lower in obese PCOS patients than in the obese and non-obese control groups. There was a positive correlation between blood lead and serum TSH levels in non-obese PCOS women; and between serum total testosterone and cadmium levels in obese PCOS women. Finally, there was negative correlation between serum magnesium and serum LH levels in non-obese PCOS women.
 the study has demonstrated higher blood levels of lead and cadmium; and lower serum levels of magnesium, calcium and manganese in PCOS groups than control subject. There were no significant differences between obese PCOS women and non-obese PCOS women in the levels of the studied hormones, elements and heavy metals.
Highlights
Citsycylop ovary syndrome (PCOS) is symptomatic nearly 6% to 10% of women of reproductive age (12–45 years old) [1]
Serum glucose levels were significantly higher in the obese Polycystic ovary syndrome (PCOS) than in the obese and non-obese control groups (P
The diagnosis of PCOS in this study was based on Rotterdam criteria that are confirmed by the results obtained from analysis data related to the measured hormones [25]
Summary
Citsycylop ovary syndrome (PCOS) is symptomatic nearly 6% to 10% of women of reproductive age (12–45 years old) [1]. Many studies have indicated increased oxidative stress in the patients with PCOS [6,7]. This creates a vicious positive feedback cycle where, for example, elevated blood epinephrine levels result in a further reduction of the magnesium concentration. The whole dollb of heavy metals and serum levels of trace elements were altered in patients with PCOS [9]. The studied women were divided into: A- Fifty-four PCOS patients, they were subdivided into two subgroups based on their body mass index (BMI), which was calculated as the ratio of the body weight in kilograms to the square of its height in meters [18]. Assay The whole blood levels of cadmium, lead and serum levels of magnesium, calcium, manganese were measured by atomic absorption spectrophotometer in Poisoning. The statistical analysis was performed using SPSS, version 16 [24]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
